These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report. Saxon SA; Knight W; Reynolds DW; Stagno S; Alford CA J Pediatr; 1973 May; 82(5):792-7. PubMed ID: 4698952 [No Abstract] [Full Text] [Related]
44. Physical and psychological development of children with early failure to thrive. Glaser HH; Heagarty MC; Bullard DM; Pivchik EC J Pediatr; 1968 Nov; 73(5):690-8. PubMed ID: 4176086 [No Abstract] [Full Text] [Related]
45. [Physical fitness of children following heart surgery]. Mocellin R Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):516-7. PubMed ID: 4751511 [No Abstract] [Full Text] [Related]
46. [Physical development and fitness in children with congenital heart defects. Preliminary report]. Bircák J; Jakubcová I; Maliariková O; Foltín F; Mruskovic S; Niks M Bratisl Lek Listy; 1971; 56(6):662-8. PubMed ID: 5157091 [No Abstract] [Full Text] [Related]
47. Surgical treatment of cyanotic congenital heart disease. Moreno-Cabral RJ; Shumway NE Hawaii Med J; 1982 Jun; 41(6):171-5. PubMed ID: 6181014 [No Abstract] [Full Text] [Related]
48. Long-term early development research in congenital heart disease (LEADER-CHD): a study protocol for a prospective cohort observational study investigating the development of children after surgical correction for congenital heart defects during the first 3 years of life. Ferentzi H; Pfitzer C; Rosenthal LM; Berger F; Schmitt KRL BMJ Open; 2017 Dec; 7(12):e018966. PubMed ID: 29288186 [TBL] [Abstract][Full Text] [Related]
49. Neurotoxicity of sedative and analgesia drugs in young infants with congenital heart disease: 4-year follow-up. Garcia Guerra G; Robertson CM; Alton GY; Joffe AR; Cave DA; Yasmin F; Dinu IA; Creighton DE; Ross DB; Rebeyka IM; Paediatr Anaesth; 2014 Mar; 24(3):257-65. PubMed ID: 24103018 [TBL] [Abstract][Full Text] [Related]
50. [Indications and possibilities of the surgical treatment of congenital heart defects without cyanosis]. Samánek M; Hucín B; Vorísková M Cesk Pediatr; 1983 Jan; 38(1):6-10. PubMed ID: 6825196 [No Abstract] [Full Text] [Related]
51. Mothers' reports of early experiences of infants with congenital heart disease. Gudermuth S Matern Child Nurs J; 1975; 4(3):155-64. PubMed ID: 1044940 [No Abstract] [Full Text] [Related]
52. Ascending aorta-right pulmonary artery shunt in infants and older patients with certain types of cyanotic congenital heart disease. Bernhard WF; Jones JE; Friedberg DZ; Litwin SB Circulation; 1971 Apr; 43(4):580-4. PubMed ID: 4102252 [No Abstract] [Full Text] [Related]
53. [Treatment of crises of cyanosis induced by premedication or by anesthesia in congenital heart diseases]. SCEBAT M Anesth Analg (Paris); 1960; 17():198-201. PubMed ID: 14442269 [No Abstract] [Full Text] [Related]
54. How infant and mother jointly contribute to developing cognitive competence in the child. Bornstein MH Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7470-3. PubMed ID: 3864165 [TBL] [Abstract][Full Text] [Related]
55. The Association Between Cyanosis and Thromboelastometry (ROTEM) in Children With Congenital Heart Defects: A Retrospective Cohort Study. Laskine-Holland ML; Kahr WH; Crawford-Lean L; Humpl T; Honjo O; Foreman C; Jain M; O'Leary JD Anesth Analg; 2017 Jan; 124(1):23-29. PubMed ID: 27861436 [TBL] [Abstract][Full Text] [Related]